CANNabinoid Drug Interaction Review (CANN-DIR™)

Non-prescription cannabidiol (CBD) and medical marijuana (cannabis) currently do not have US Food and Drug Administration (FDA)-approved prescribing information nor a dedicated resource to evaluate potential cannabinoid drug-drug interactions with other medications. The CANNabinoid Drug Interaction...

Descripción completa

Detalles Bibliográficos
Autores principales: Kocis, Paul T., Wadrose, Samuel, Wakefield, Ryan Lee, Ahmed, Aqib, Calle, Renata, Gajjar, Rohan, Vrana, Kent E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Product Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940648/
https://www.ncbi.nlm.nih.gov/pubmed/36814686
http://dx.doi.org/10.1159/000528528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940648/
https://www.ncbi.nlm.nih.gov/pubmed/36814686
http://dx.doi.org/10.1159/000528528

Ejemplares similares